Stereotaxis (STXS) Debt Ratio (2010 - 2026)

Stereotaxis (STXS) posted quarterly Debt Ratio of 0.1 for Q1 2026, up 4.06% quarter-over-quarter from 0.09 in Q4 2025.

Stereotaxis (STXS) Debt Ratio (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Debt Ratio for 12 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

In Q1 2026, Debt Ratio changed N/A year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (changed N/A YoY), while the FY2025 annual figure was 0.09, down 22.38% from the prior year.
Debt Ratio advanced to 0.1 in Q1 2026 per STXS's latest filing, from 0.09 in the prior quarter.
Across five years, Debt Ratio topped out at 0.12 in Q3 2025 and bottomed at 0.09 in Q4 2025.
Historically, Debt Ratio has averaged 0.11 across 3 years, with a median of 0.11 in 2024.
On a YoY basis, Debt Ratio climbed as much as 22.38% in 2025 and fell as far as 22.38% in 2025.
Stereotaxis' Debt Ratio stood at 0.12 in 2024, then retreated by 22.38% to 0.09 in 2025, then increased by 4.06% to 0.1 in 2026.
Business Quant data shows STXS's Debt Ratio at 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.12 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	0.33
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	0.15
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	0.07
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	0.32
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	0.05
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	0.36
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	0.20
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	0.48
10	Stereotaxis	141.91 Mn	127.29 Mn	3.79 Mn	0.10

Download Data